Elio Venturini

ORCID: 0000-0001-7223-7574
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Health and Mental Health
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Atrial Fibrillation Management and Outcomes
  • Cardiovascular and exercise physiology
  • Cancer survivorship and care
  • Cardiac Arrhythmias and Treatments
  • Heart Failure Treatment and Management
  • Cardiac Imaging and Diagnostics
  • Iron Metabolism and Disorders
  • Venous Thromboembolism Diagnosis and Management
  • Cardiac pacing and defibrillation studies
  • Lipoproteins and Cardiovascular Health
  • Health Systems, Economic Evaluations, Quality of Life
  • Acute Myocardial Infarction Research
  • Hemoglobinopathies and Related Disorders
  • Erythropoietin and Anemia Treatment
  • Cardiovascular Function and Risk Factors
  • Cardiovascular Effects of Exercise
  • Heart Rate Variability and Autonomic Control
  • Food Allergy and Anaphylaxis Research
  • Climate Change and Health Impacts
  • Viral Infections and Immunology Research
  • Lung Cancer Treatments and Mutations
  • Adipokines, Inflammation, and Metabolic Diseases
  • Peripheral Nerve Disorders

Centre National de la Recherche Scientifique
2025

Institut de Recherche pour le Développement
2025

École Pratique des Hautes Études
2025

Institut des Sciences de l'Evolution de Montpellier
2025

Université de Montpellier
2025

Azienda Usl Toscana Centro
2019-2024

Ospedale di Livorno
2007-2024

Hospital of Prato
2015-2023

Dipartimento della Protezione Civile
2023

Ca' Foncello Hospital
2017

Cardiac rehabilitation (CR) programs are underutilized globally, especially by women. In this study we investigated sex differences in CR barriers across all world regions, to our knowledge for the first time, characteristics associated with greater women, and women's greatest according enrollment status.

10.1016/j.cjca.2023.07.016 article EN cc-by-nc-nd Canadian Journal of Cardiology 2023-09-25

Background/Objectives: This study assessed the proportion of secondary cardiovascular prevention patients who achieved low-density lipoprotein (LDL) cholesterol targets as per 2019 ESC/EAS Dyslipidemia Guidelines. We also evaluated whether lipid-lowering therapies (LLTs) were adjusted in not meeting and analyzed likelihood these modifications achieving recommended levels. Methods: A multicenter, cross-sectional observational retrospectively reviewed medical records 1909 outpatients 9 Italian...

10.3390/jcm14020493 article EN Journal of Clinical Medicine 2025-01-14

Abstract Aims Tailored education is recommended for cardiac patients, yet little known about information needs in areas of the world where it most needed. This study aims to assess (i) measurement properties Information Needs Cardiac Rehabilitation short version (INCR-S) scale and (ii) patient’s globally. Methods results In this cross-sectional study, English, simplified Chinese, Portuguese, or Korean versions INCR-S were administered in- out-patients via Qualtrics (January 2022–November...

10.1093/eurjpc/zwae148 article EN cc-by-nc European Journal of Preventive Cardiology 2024-05-09

Background: Various experimental and clinical observations suggest changes in sympathetic vagal neural regulatory mechanisms play a critical role altering cardiac electrical properties favor the occurence of arrhythmic events. There is limited information about influences autonomic tone on development episodes paroxismal atrial fibrillation patients with no evidence organic heart disease. The aim this study was to investigate sympatho‐vagal balance 5 minutes before onset fibrillation....

10.1111/j.1540-8159.1999.tb00538.x article EN Pacing and Clinical Electrophysiology 1999-05-01

The effects of refined carbohydrate consumption on the prevalence myopia have been little studied. aim this study is to explore potential link between and in individuals aged 40 or under population-based Constances cohort, conjunction with other known risk confounding factors. association probability at least one eye was tested for 5271 participants, younger, education level, physical activity, energy intake, age, sex, fasting blood glucose, Body Mass Index (BMI), Mediterranean diet quality....

10.1016/j.clnesp.2025.03.033 article EN cc-by Clinical Nutrition ESPEN 2025-03-01

Abstract This Delphi consensus by 28 experts from the European Association of Preventive Cardiology (EAPC) provides initial recommendations on how cardiovascular rehabilitation (CR) facilities should modulate their activities in view ongoing coronavirus disease 2019 (COVID-19) pandemic. A total number 150 statements were selected and graded Likert scale [from −5 (strongly disagree) to +5 agree)], starting six open-ended questions (i) referral criteria, (ii) optimal timing setting, (iii) core...

10.1093/eurjpc/zwaa080 article EN other-oa European Journal of Preventive Cardiology 2020-11-07

The COVID-19 outbreak is having a significant impact on both cardiac rehabilitation (CR) inpatient and outpatient healthcare organization. variety of clinical care scenarios we are observing in Italy depends the region, organization local services hospital involved. Some wards have been closed to make room dedicated beds or quarantine exposed health personnel. In other cases, CR units converted transformed into units. present document aims at defining state art during pandemic, through...

10.4081/monaldi.2020.1439 article EN cc-by-nc Monaldi Archives for Chest Disease 2020-06-15

Cardio-oncology rehabilitation (CORE) is not only an essential component of cancer but also a pillar preventive cardio-oncology. comprehensive model based on multitargeted approach and its efficacy has been widely documented; when compared with 'exercise only' programme, CORE demonstrates better outcome. It involves nutritional counselling, psychological support, cardiovascular (CV) risk assessment, it directed to very demanding population heavy burden CV diseases driven by physical...

10.1093/eurheartjsupp/suae030 article EN cc-by-nc European Heart Journal Supplements 2024-04-01

Heart rate recovery (HRR) is a marker of vagal tone, which powerful predictor mortality in patients with cardiovascular disease. Sacubitril/valsartan (S/V) treatment for heart failure reduced ejection fraction (HFrEF), impressively impacts outcome. This study aims at evaluating the effects S/V on HRR and its correlation cardiopulmonary indexes HFrEF patients.Patients admitted to outpatients' services were screened out inclusion. was administered according guidelines. Up-titration performed...

10.3390/jcm9061897 article EN Journal of Clinical Medicine 2020-06-17

atherosclerotic process inexorably advances in patients reaching low-density lipoprotein cholesterol (LDL-C) targets. An attractive hypothesis is that particles (very (VLDL), intermediate-density (IDL)), could contribute to residual risk. The present study aims investigate the relationship between carotid intima-media thickness (IMT) and different subfractions a cohort of healthy postmenopausal women.75 women, at LDL-C target levels without overt cardiovascular disease, underwent biochemical...

10.3390/jcm9051422 article EN Journal of Clinical Medicine 2020-05-11

Effective anticancer treatments have dramatically improved the outcome of patients with cancer, but cardiac toxicity reduces their clinical efficacy in a non-negligible percentage patients. Sacubitril/valsartan is new paradigm treatment chronic heart failure, reduced ejection fraction due to enhancement natriuretic peptides' properties when coupled blocking effect on angiotensin II type 1 (AT1) receptors. As other conditions failure potentially reversible declines function, wearable...

10.3389/fcvm.2022.801143 article EN cc-by Frontiers in Cardiovascular Medicine 2022-03-01

Iron deficiency anemia (IDA) is frequent after cardiac surgery and associated with increased morbidity mortality. In a retrospective study, we analyzed 106 patients IDA (hemoglobin [Hb] ≤ 12 g/dl in women 13 men, transferrin saturation [TSAT] 20%) on admission to Cardiac Rehabilitation Unit surgery. The were divided into two groups, one was treated oral sucrosomial iron (SI) the other intravenous ferric carboxymaltose (FCM). Patients received single 1000 mg dose of FCM from day...

10.1016/j.ijcha.2022.101038 article EN cc-by-nc-nd IJC Heart & Vasculature 2022-05-02

Cardiovascular risk factors (CVRFs) predict cardiotoxicity in cancer patients but their role late cardiac toxicity is less clear.This was a retrospective analysis of treated with anthracyclines (A) and/or trastuzumab (T) and correlation early (≤5 years) or (>5 toxicity, baseline CVRFs at time.A total 610 were included, 422 (Group A) 188 without B) CVRFs. In group A incidence 4.7% all events during treatment immediately after [mean onset time 0.7 years (range=0.2-1.6)]. Events rate 3.2% B...

10.21873/anticanres.13775 article EN Anticancer Research 2019-09-30

There has been an increase in the use of central venous catheters (CVCs) clinical practice. One most dangerous complications associated with their is symptomatic or asymptomatic thrombosis (T), sometimes superior vena cava (SVC) syndrome, resulting from impaired drainage. The right heart clots can induce increased risk mortality due potential pulmonary embolism (PE). We report a case 83-year-old woman whom was detected after echocardiogram. Echocardiography demonstrated cardiac mass, and T...

10.1155/2012/469619 article EN cc-by Case Reports in Vascular Medicine 2012-01-01

In recent years, direct-acting oral anticoagulants (DOACs) have entered clinical practice for stroke prevention in non-valvular atrial fibrillation or and treatment of venous thromboembolism. However, remaining uncertainty regarding DOAC use some scenarios commonly encountered the real world has not been fully explored trials.We report on a Delphi consensus process patients. The dealt with 9 main topics: (i) DOACs vs vitamin K antagonists (AF) patients; (ii) therapeutic options patients...

10.1016/j.cjco.2020.07.016 article FR cc-by-nc-nd CJC Open 2020-07-23
Coming Soon ...